Brian J. Parks

Researcher

University of Arkansas for Medical Sciences

faculty

3 h-index 12 pubs 29 cited

Research Areas

Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Pharmacological Effects and Toxicity Studies Maternal and Perinatal Health Interventions Behavioral and Psychological Studies Health Sciences Research and Education Health Literacy and Information Accessibility

Links

Research Group

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Brian J. Parks conducts research focused on the pharmacological effects of substances, particularly in preclinical models. His work has investigated the pharmacodynamics of deuterated buprenorphine, examining its metabolism and its interaction with norbuprenorphine in the context of neonatal opioid withdrawal syndrome. Parks has also studied the impact of deuterated buprenorphine on mitigating fentanyl effects in pregnant rats. His research extends to the effects of early life adversity on substance use, including ethanol self-administration and adrenergic receptor expression in adolescent rats. Additionally, Parks has analyzed public discourse surrounding substances like kratom, examining responses to FDA inquiries and the motivations for self-medication. He has also contributed to the development and evaluation of surveys related to healthcare education, specifically for nurse practitioners.

Metrics

  • h-index: 3
  • Publications: 12
  • Citations: 29

Selected Publications

  • Development and Psychometric Evaluation of a Theory-Based Preceptorship Survey for Nurse Practitioners (2025) DOI
  • Limited bedding and nesting increases ethanol drinking in female rats (2024) DOI
  • Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023) DOI
  • Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2023) DOI
  • Effects of a two-hit model of early life adversity on oral ethanol self-administration and adrenergic receptor expression in adolescent rats (2023) DOI
  • 481 Interactions between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome (2023) DOI
  • Interaction between buprenorphine and norbuprenorphine in neonatal opioid withdrawal syndrome. (2022) DOI
  • Deuterated buprenorphine retains pharmacodynamic properties of buprenorphine and resists metabolism to the active metabolite norbuprenorphine in rats (2022) DOI
  • Qualitative content analysis of public responses to an FDA inquiry on the impact of scheduling changes to kratom (2022) DOI
  • Effects of prenatal opioid exposure and early life adversity on opioid‐induced antinociception (2022) DOI
  • 384 Motives for kratom self-medication: contents of public comments solicited by the FDA (2022) DOI

Collaborators

Researchers in the database who share publications

Lisa K. Brents University of Arkansas for Medical Sciences 11 shared publications Julia Tobacyk University of Arkansas for Medical Sciences 9 shared publications Michael D. Berquist University of Arkansas for Medical Sciences 7 shared publications Jeffery H. Moran University of Arkansas for Medical Sciences 2 shared publications Alexander W. Alund National Center for Toxicological Research 2 shared publications Madison McGraw University of Arkansas for Medical Sciences 2 shared publications Nakita Lovelady University of Arkansas for Medical Sciences 1 shared publication Leonie DeClerk University of Arkansas for Medical Sciences 1 shared publication

Similar Researchers

Based on overlapping research topics

Michael D. Berquist University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Pharmacological Effects and Toxicity Studies
Strong match 5 shared topics
Catheryn D. Wilson University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Pharmacological Effects and Toxicity Studies
Strong match 5 shared topics
Lisa K. Brents University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Pharmacological Effects and Toxicity Studies
Good match 5 shared topics
William M. Blakemore National Center for Toxicological Research
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Julia Tobacyk University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Maternal and Perinatal Health Interventions
Good match 5 shared topics
Heidi D. Hughes-Meredith University of Arkansas for Medical Sciences
Neuroscience and Neuropharmacology Research Substance Abuse Treatment and Outcomes Pharmacological Effects and Toxicity Studies
Good match 4 shared topics